Literature DB >> 8232356

Reliability of the Columbia scale for assessing signs of Parkinson's disease.

M A Hely1, T Chey, A Wilson, P M Williamson, D J O'Sullivan, D Rail, J G Morris.   

Abstract

Inter- and intrarater reliability in scoring the signs of Parkinson's disease using the original Columbia scale and a modified version of this, the Sydney scale, were assessed in five neurologists participating in a long-term study of Parkinson's disease. Scoring was done on video recordings of 41 patients whose disability ranged from mild to severe. Although all the neurologists were familiar with the scales and had received training designed to produce uniformity of scoring, interrater reliability was poor. The mean score for the Columbia scale varied from 18.6 to 30 and for the Sydney scale from 15.2 to 23.2. By contrast, intrarater reliability was good. This study highlights the limitations of clinical rating scales in Parkinson's disease when more than one rater is used. In designing clinical trials, every effort should be made to ensure that the same patient is always assessed by the same rater.

Entities:  

Mesh:

Year:  1993        PMID: 8232356     DOI: 10.1002/mds.870080409

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  8 in total

1.  Gait quantitation in Parkinson's disease--locomotor disability and correlation to clinical rating scales.

Authors:  P Vieregge; H Stolze; C Klein; I Heberlein
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 2.  Cost effectiveness of pharmacotherapies in early Parkinson's disease.

Authors:  Karla M Eggert; Jens P Reese; Wolfgang H Oertel; Richard Dodel
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

3.  [A biomechanical analysis of cyclical hand motor function: a pilot study in different Parkinsonian syndromes].

Authors:  T Wolfsegger; I Rotaru; R Topakian; R Pichler; M Sonnberger; F T Aichner; H Schwameder
Journal:  Nervenarzt       Date:  2012-06       Impact factor: 1.214

Review 4.  Health-related quality-of-life measurement in patients with Parkinson's disease.

Authors:  C Jenkinson; R Fitzpatrick; V Peto
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

5.  Outcome measure for parkinsons disease.

Authors:  F Fitzpatrick; C Jenkinson; V Peto
Journal:  Br J Gen Pract       Date:  1995-08       Impact factor: 5.386

6.  The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

Authors:  V Peto; C Jenkinson; R Fitzpatrick; R Greenhall
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

7.  The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.

Authors:  M A Hely; J G Morris; W G Reid; D J O'Sullivan; P M Williamson; D Rail; G A Broe; S Margrie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

Review 8.  Therapeutic studies in hepatic encephalopathy.

Authors:  Kevin D Mullen; Piero Amodio; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.